Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$12,823,107
+$5,024,378 QoQ
Shares Held
10,691
+26.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.06%
of 13F equity value
Holder Rank
#1,125
of 4,605 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHNIEDERS CAPITAL MANAGEMENT, LLC. holds $49,625,900 across 9 Drug Manufacturers - General names. LLY ranks #2 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
76,793 | $19,503,118 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
10,691 | $12,823,107 | |
| 3 | AMGN |
Amgen Inc
|
27,550 | $9,976,406 | |
| 4 | ABBV |
AbbVie Inc.
|
19,159 | $4,821,170 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,070 | $1,165,495 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,219 | $473,578 | |
| 7 | NVS |
Novartis AG
|
2,116 | $331,619 | |
| 8 | NVO |
Novo Nordisk A S
|
5,751 | $275,702 |
All Filings in LLY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,823,107 | 10,691 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $7,798,729 | 8,479 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $9,073,524 | 8,443 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $6,432,853 | 8,431 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||